We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$224B
AUM Growth
+$21B
Cap. Flow
+$7.48B
Cap. Flow %
3.33%
Top 10 Hldgs %
24.57%
Holding
10,190
New
1,427
Increased
4,227
Reduced
3,278
Closed
1,044

Top Buys

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$798M
2
T icon
AT&T
T
+$527M
3
MCHP icon
Microchip Technology
MCHP
+$472M
4
NFLX icon
Netflix
NFLX
+$446M
5
PNC icon
PNC Financial Services
PNC
+$444M

Top Sells

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$694M
2
KEY icon
KeyCorp
KEY
+$401M
3
DE icon
Deere & Co
DE
+$322M
4
CSX icon
CSX Corp
CSX
+$318M
5
NXPI icon
NXP Semiconductors
NXPI
+$314M

Sector Composition

Rank Sector Weight
1 Financials 5.93%
2 Technology 4.66%
3 Healthcare 4.45%
4 Industrials 4.14%
5 Consumer Discretionary 3.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RMTI icon
7476
PUT
Rockwell Medical
RMTI
$29.2M
$287K ﹤0.01%
618
+157
+34% +$76K
FBR
7477
CALL
DELISTED
Fibria Celulose Sa
FBR
$287K ﹤0.01%
+15,500
New +$295K
MCY icon
7478
PUT
Mercury Insurance
MCY
$5.84B
$286K ﹤0.01%
5,700
+400
+8% +$19.9K
MXL icon
7479
PUT
MaxLinear
MXL
$7.69B
$286K ﹤0.01%
14,400
-5,200
-27% -$94.7K
PNR icon
7480
PUT
Pentair
PNR
$10.6B
$286K ﹤0.01%
6,600
-5,200
-44% -$226K
SPXC icon
7481
PUT
SPX Corp
SPXC
$10.9B
$286K ﹤0.01%
+8,600
New +$303K
VEON icon
7482
VEON
VEON
$3.93B
$286K ﹤0.01%
3,952
+2,879
+268% +$209K
RVNC
7483
PUT
DELISTED
Revance Therapeutics, Inc.
RVNC
$286K ﹤0.01%
11,500
-5,000
-30% -$136K
NVTR
7484
CALL
DELISTED
Nuvectra Corporation Common Stock
NVTR
$286K ﹤0.01%
+13,000
New +$250K
SGG
7485
DELISTED
iPath Series B Bloomberg Sugar Subindex Total ReturnSM ETN
SGG
$286K ﹤0.01%
+7,472
New +$296K
SDOW icon
7486
ProShares UltraPro Short Dow 30
SDOW
$186M
$285K ﹤0.01%
+311
New +$318K
TTEC icon
7487
PUT
TTEC Holdings
TTEC
$77.9M
$285K ﹤0.01%
+11,000
New +$320K
PS
7488
CALL
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$285K ﹤0.01%
+8,900
New +$262K
CEFL
7489
DELISTED
ETRACS Monthly Pay 2xLeveraged Closed-End Fund ETN
CEFL
$285K ﹤0.01%
+18,138
New +$285K
FRST icon
7490
Primis Financial Corp
FRST
$413M
$284K ﹤0.01%
17,563
-6,086
-26% -$105K
HUYA
7491
Huya Inc
HUYA
$529M
$284K ﹤0.01%
12,040
+3,482
+41% +$104K
LABU icon
7492
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$629M
$284K ﹤0.01%
+152
New +$299K
XNCR icon
7493
CALL
Xencor
XNCR
$1.74B
$284K ﹤0.01%
7,300
+1,400
+24% +$57.1K
NPTN
7494
PUT
DELISTED
NEOPHOTONICS CORP
NPTN
$284K ﹤0.01%
+34,200
New +$260K
COBZ
7495
DELISTED
CoBiz Financial,Inc
COBZ
$284K ﹤0.01%
12,817
-55,741
-81% -$1.25M
ANIK icon
7496
PUT
Anika Therapeutics
ANIK
$288M
$283K ﹤0.01%
6,700
+400
+6% +$15.8K
BBAX icon
7497
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
$6.75B
$283K ﹤0.01%
+5,727
New +$285K
IPI icon
7498
PUT
Intrepid Potash
IPI
$493M
$283K ﹤0.01%
7,890
+1,420
+22% +$52K
MVV icon
7499
ProShares Ultra MidCap400
MVV
$166M
$283K ﹤0.01%
6,206
-4,189
-40% -$189K
ORAN
7500
CALL
DELISTED
Orange
ORAN
$283K ﹤0.01%
17,800
+3,000
+20% +$49.5K

Similar funds

Citadel Advisors's Q3 2018 Portfolio in Review

As of Q3 2018, Citadel Advisors held 10,190 positions worth $224B, up 10% from $203B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Citadel Advisors deployed $7.48B of net new capital in Q3 2018, opening 1,427 new positions and adding to 4,227 existing holdings. Its largest new stake was Alibaba: 1,030,311 shares worth $170M.

By sector, the portfolio is most concentrated in Financials at 5.9% of assets, down from 6.2% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Goldman Sachs, an estimated $694M trimmed.

  • Citadel Advisors's largest Q3 2018 buy was Alibaba: 1,030,311 shares worth $170M.
  • Citadel Advisors added most to Morgan Stanley in Q3 2018, an estimated $798M increase.
  • Citadel Advisors's biggest Q3 2018 reduction was Goldman Sachs, cutting an estimated $694M.
  • Citadel Advisors fully exited XL Group Ltd. in Q3 2018, selling an estimated $207M.
  • Citadel Advisors's ten largest holdings make up 25% of its $224B portfolio in Q3 2018.
  • Citadel Advisors opened 1,427 new positions and closed 1,044 in Q3 2018.
  • Citadel Advisors's portfolio value rose 10% quarter-over-quarter to $224B.

Based on Citadel Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.